Option Investor
Newsletter

2 ADDITIONAL POSTIONS added to FEBRUARY RECOMMENDED LIST

HAVING TROUBLE PRINTING?
Printer friendly version


Two put writes added to our FEBRUARY RECOMMENDATION LIST

We are recommending the following two (2) put writes on the following issues


PGNX - Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. It offers products for the areas of symptom management and supportive care, and the treatment of HIV infection and cancer


OVTI - OmniVision Technologies, Inc. and its subsidiaries engage in the design, development, and marketing of semiconductor image sensor devices. Its principal products, referred under the name CameraChips, are single chip complementary metal oxide semiconductor solutions that integrate various functions, including image capture, image processing, color processing, and the conversion and output of the processed image or video stream. The resulting image or video stream can be displayed on either digital or analog equipment, such as computers or televisions.


We are recommending the following specific put writes


PGNX $27.92
SELL PGNX FEB SYM: GUB-NX
Target Price $25.00 22.5 Put
Potential Profit(10 x = $250.00
Initial Margin $5,834 10 (contracts)
Return on Investment 4.29%
Cost Basis in Stock = $22.25
Days to Expiration = 36
Stock goes on Watch List Price at: $24.50
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $22.50


OVTI $25.04
SELL OVTI FEB SYM: UCM-NX
Target Price $25.00 22.5 Put
Potential Profit(10 x = $250.00

Initial Margin $5,258 10 (contracts)
Return on Investment 4.75%
Cost Basis in Stock = $22.25
Days to Expiration = 36
Stock goes on Watch List Price at: $24.50
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $22.50

When these positions are filled this will bring our FEBRUAY recommendation
list to eight (8) positions.


There are NO issues currently on the WATCH list at this time


WATCH LIST

NONE - No issues currently on the WATCH LIST

Option Writers Newsletter Archives